Propofol-butorphanol Anesthesia During Uterine Curettage (PABADUC)
Propofol-butorphanol Combined Anesthesia During Uterine Curettage on Abortion
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Jiangsu
-
Nanjing, Jiangsu, China, 210004
- Nanjing Maternal and Child Health Care Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ASA status I-II;
- Performing abortion operation (medical- or drug-induced);
- Requiring painless abortion;
Exclusion Criteria:
- < 19yrs, and >= 45yrs;
- History of central active drugs administration;
- Drug abuse;
- Hypertension;
- Diabetes;
- Any other chronic diseases;
- Allergy to the study drugs;
- Habit of over-volume alcohol drinking;
- Records of history of centrally active drug use and psychiatry;
- Any organic disorders.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: 1
Propofol-fentanyl combined anesthesia
|
Combined anesthesia with propofol (2-2.5mg/kg) and fentanyl (5 μg)
Other Names:
|
|
EXPERIMENTAL: 2
Propofol-butorphanol combined anesthesia
|
Combined anesthesia with propofol (2-2.5 mg/kg) and butorphanol (1mg)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Intraoperative awareness
Time Frame: During the whole process of anesthesia
|
During the whole process of anesthesia
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Bispectral Index (BIS) value
Time Frame: During the whole process of anesthesia
|
During the whole process of anesthesia
|
|
Anesthetic consumptions
Time Frame: From the start of operation to the end of surgical procedures
|
From the start of operation to the end of surgical procedures
|
|
Postoperative pain
Time Frame: Since the end of the operation to 48 h follow-up.
|
Since the end of the operation to 48 h follow-up.
|
|
Postoperative bleeding
Time Frame: Since the end of operation to 48 h follow-up
|
Since the end of operation to 48 h follow-up
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Analgesics, Opioid
- Narcotics
- Adjuvants, Anesthesia
- Narcotic Antagonists
- Respiratory System Agents
- Antitussive Agents
- Fentanyl
- Butorphanol
Other Study ID Numbers
Other Study ID Numbers
- NMU-2008-FY10MZ31
- NJFY0811-MZ02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.